Audio By Carbonatix
Uganda will begin human trials of a Covid-19 vaccine in November, the Daily Monitor newspaper reports quoting ministry of health officials.
The vaccine, called Self Replicating RNA, has been developed through a partnership between Uganda Virus Research Institute (UVRI) and Imperial College in the UK.
The head of a presidential taskforce on epidemics, Monica Musenero, is quoted as saying the first trial will be conducted on 10 Ugandans.
If successful, a second trial will involve about 100 to 200 people followed by a final trial of between 1,000 and 3,000 people, she said.
The bulk of the project is being financed by the UK university.
The East Africa country has to date confirmed more than 7,000 coronavirus cases and 75 deaths.
Latest Stories
-
Muzic Mensah selected for Boomplay’s inaugural ‘NEXT WAVE’ Programme
4 hours -
Prime Insight to tackle legal vacation controversy and $1million AKSA bribery case
4 hours -
Ghanaian evacuee from South Africa dies on arrival in Accra
5 hours -
POS Foundation raises alarm over student cohabitation, sexual harassment on university campuses
6 hours -
Nandom NPP primary heats up as four candidates enter 2028 race
6 hours -
Mangione admits killing healthcare CEO and pleads guilty to federal charges
6 hours -
The Invite to The Odyssey: 12 of the best films of 2026 so far
6 hours -
Ayra Starr on her secret relationship and teasing Stevie Wonder
7 hours -
NPP Ashanti holds vigil in support of Wontumi as lawyers appeal conviction
7 hours -
TCDA targets higher crop yields as farmers receive inputs
7 hours -
Kofi Amoako Attah inducted into 11th Corporate Ghana Hall of Fame
7 hours -
Newsfile to discuss AKSA energy deal, legal vacation and GoldBod losses
7 hours -
Gushegu MCE says slain Yiidana was targeted as police investigate killing of chief and son
8 hours -
President Mahama reiterates commitment to link regional capitals with good roads
8 hours -
Ex-Cambridge professor at centre of plagiarism row found dead
8 hours